2016 ESG REPORT Being a Customer-Focused Responsible Investor
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Press Release Paris // December 8, 2016
PRESS RELEASE PARIS // DECEMBER 8, 2016 The 15th edition of the Private Equity Exchange & Awards was held in Paris on December 8, 2016. 1,200 participants – Limited Partners, Private Equity Funds and Corporate Executives – gathered for this major Pan-European summit on private equity and restructuring followed by a high-class evening ceremony rewarding the best performers among LBO Funds, Limited Partners and Management Teams. AN INTENSIVE ONE-DAY PROGRAM… 80 outstanding speakers from all over Europe shared their expertise through interactive round-tables and keynote speeches in three main tracks: International LBO & Fundraising; LBO & Management; Underperformance, Restructuring & Private Equity. Experts included: Pascal Blanqué, Chief Investment Officer, Amundi Blair Jacobson, Partner, Ares Management Mark Ligertwood, Partner, Dunedin Fabrice Nottin, Partner, Apollo Global Management Jean-Baptiste Wautier, Managing Partner, BC Partners, etc... DOWNLOAD THE SPEAKERS’ LINE UP …FOCUSING ON NETWORKING OPPORTUNITIES The Private Equity Exchange & Awards promoted targeted networking opportunities in several ways. The Business lunch allowed participants to develop their network and meet participants with diverse profiles. Thanks to the exclusive One-to-One Meetings, participants benefited from a targeted networking planning their meetings ahead of the event through a dedicated online platform. …CONCLUDED BY A PRESTIGIOUS GALA EVENING The gala dinner followed by the Awards Ceremony was the crowning achievement of the event, rewarding the best Private Equity players – LBO, Venture and Growth Capital Funds, Limited Partners and Management Teams – on the long run. Over 80 jury members, top Limited Partners and Asset Management professionals, committed themselves to assess the application forms submitted by carefully preselected nominees. Laureates were rewarded on stage in front of more than 450 private equity players. -
Value in Private Equity: Where Social Meets Shareholder 3 OPPORTUNITIES ALIGNED
VALUE IN PRIVATE EQUITY WHERE SOCIAL MEETS SHAREHOLDER By Mark Hepworth Big Issue Invest March 2014 2 MOVING TOWARDS AN ERA OF OPPORTUNITY FOR ALL... The imbalance of opportunity in society is as striking today as it ever was. In my opinion though, this lack of opportunity is caused, not so much by opportunity not being there, but because of the lack of educational qualifications, or other criteria, such as direction and focus being absent in poorer sections of society. Clearly someone who attended private school, comes from a wealthy and educated family, and who completed their education to degree level is more likely to achieve than someone who was brought up as part of a one parent family, located in an inner city borough, didn’t attend much school and left at the earliest opportunity without any exam passes. Opportunity is always there for those naturally gifted, or lucky enough to spot it, or perhaps those educated enough to recognise it. I recently had lunch with a leading politician and mentioned my belief that we simply must find a way of linking the powerful stallions of free enterprise to the carriage of humanity that follows behind. It is essential in a modern democratic society that we work toward inclusion for all. Forget making the rich poorer, let’s make the poor richer. To most, the goal of private equity investment is typically seen as working in direct conflict to this goal of social inclusion. The media tends to distort and exaggerate the sector like a pantomime villain - asset stripping, job losses, financial engineering...the list goes on. -
Boosey & Hawkes
City Research Online City, University of London Institutional Repository Citation: Howell, Jocelyn (2016). Boosey & Hawkes: The rise and fall of a wind instrument manufacturing empire. (Unpublished Doctoral thesis, City, University of London) This is the accepted version of the paper. This version of the publication may differ from the final published version. Permanent repository link: https://openaccess.city.ac.uk/id/eprint/16081/ Link to published version: Copyright: City Research Online aims to make research outputs of City, University of London available to a wider audience. Copyright and Moral Rights remain with the author(s) and/or copyright holders. URLs from City Research Online may be freely distributed and linked to. Reuse: Copies of full items can be used for personal research or study, educational, or not-for-profit purposes without prior permission or charge. Provided that the authors, title and full bibliographic details are credited, a hyperlink and/or URL is given for the original metadata page and the content is not changed in any way. City Research Online: http://openaccess.city.ac.uk/ [email protected] Boosey & Hawkes: The Rise and Fall of a Wind Instrument Manufacturing Empire Jocelyn Howell PhD in Music City University London, Department of Music July 2016 Volume 1 of 2 1 Table of Contents Table of Contents .................................................................................................................................... 2 Table of Figures...................................................................................................................................... -
RRP Sector Assessment
OrbiMed Asia Partners III, LP Fund (RRP REG 51072) OWNERSHIP, MANAGEMENT, AND GOVERNANCE A. The Fund Structure 1. The Asian Development Bank (ADB) proposes to invest in OrbiMed Asia Partners III, LP Fund (OAP III), which is a Cayman Islands exempted limited partnership seeking to raise up to $500 million in capital commitments. It is managed by OrbiMed Asia GP III, LP (the general partner), a Cayman Islands exempted limited partnership. The sole limited partner of the general partner is OrbiMed Advisors III Limited, a Cayman Islands exempted company. OrbiMed Advisors LLC (the investment advisor), a registered investment advisor with the United States (US) Securities and Exchange Commission, will provide investment advisory services to OAP III. This structure is illustrated in the figure below. Table 1 shows the ultimate beneficial owners (UBOs) of the general partner and the investment advisor. Table 1: Ultimate Beneficial Owners of the General Partner and the Investment Advisor (ownership stake, %) Name Investment Advisor General Partner Sven H. Borho (~10–25%) (~8%) Alexander M. Cooper (~8%) Carl L. Gordon (~10–25%) (~8%) (also Director) Geoffrey C. Hsu (<5%) (~8%) Samuel D. Isaly (~50–75%) (~8%) W. Carter Neild (<5%) (~8%) (also Director) Jonathan T. Silverstein (~5–10%) (~8%) (also Director) Sunny Sharma (~8%) (also Officer) Evan D. Sotiriou (~8%) David G. Wang (~8%) (also Officer) Jonathan Wang (~8%) (also Officer) Sam Block III (~8%) Source: OrbiMed Group. 2 2. Investors. The fund held a first closing of approximately $233.5 million on 1 March 2017, and a second closing of approximately $137.6 million on 26 April 2017. -
Monthly M&A Insider
QUA E D RTERLY ITION A MERGERMARKET REPORT ON GLOBAL M&A ACTIVITY MONTHLY M&A INSIDER JULY 2013 INSIDE: GLOBAL OVERVIEW LATIN AMERICA NORTH AMERICA ASIA-PACIFIC EUROPE MIDDLE EAST & AFRICA ABOUT MERRILL DATASITE AND MERRILL CORPORATION Monthly M&A Insider | July GLOBAL OVERVIEW Q2 2013 finds the global M&A climate in a state of inertia. Buyers have sought to fortify against risk at the expense of growth, which has hindered both trade sales and private equity activity. Deal volume declined 13% year-on-year (YoY) to 2,890 deals, while value dropped 15% YoY to US$480bn. Sustained activity in the Pharma, Medical & The continued importance of secondary buyouts Biotech sector A major story in Q2 2013 was the prevalence of secondary The Pharma, Medical & Biotech sector has been a fertile source buyouts. Secondary buyouts (SBOs) became increasingly of M&A throughout Q2 2013. When comparing Q2 2013 with popular in 2012, and this trend has continued into 2013. Q2 2012, the sector has decreased by a slim 5% in volume, but Exits and buyouts are down YoY in Q2 both in terms of volume by value, the sector has grown YoY by a quarter. High-value and value, but secondary buyouts’ value have increased 8% activity concentrated at the upper-end of the market took place to US$25.5bn, even as volume dropped 17% YoY to 45 deals. throughout Q2. SBOs’ increased frequency has been brought about largely by lack of better options: listing became less popular because of Much of this large-cap activity was driven by private equity instability in equity markets; and controversial valuations have players, who have been particularly active in the sector. -
Understanding Private Equity. What Is Private Equity? EXAMPLES of PRIVATELY HELD COMPANIES
Understanding private equity. What is private equity? EXAMPLES OF PRIVATELY HELD COMPANIES: A private equity investor is an individual or entity that invests capital into a private company (i.e. firms not traded on a public exchange) in exchange for equity interest in that business. In the US, there are approximately 18,000 publicly traded companies, and more than 300,000 privately held companies. WHO MIGHT SEEK A PRIVATE EQUITY INVESTOR AS A SOURCE OF CAPITAL? • Companies looking to fund a capital need that is beyond traditional bank financing • Owners considering a partial or complete sale of their business • Managers looking to buy a business Private equity strategies. EXAMPLES OF PRIVATE EQUITY FIRMS: MOST PRIVATE EQUITY INVESTORS WILL LIMIT THEIR INVESTMENTS TO ONE OR TWO OF THE FOLLOWING STRATEGIES: • Angel investing • Growth capital • Venture capital • Distressed investments • Leveraged buyouts (LBO) • Mezzanine capital Sources of capital for PE funds. THERE ARE TWO TYPES OF PRIVATE EQUITY FIRMS: • Firms with a dedicated fund, with the majority of the capital sourced from institutional investors (i.e. pension funds, banks, endowments, etc.) and accredited investors (i.e. high net worth individual investors) • Firms that raise capital from investors on a per-deal basis (pledge funds) INVESTMENT DURATION AND RETURNS. • Typical investment period is 3−10 years, after which capital is distributed to investors • Rates of return are higher than public market returns, typically 15−30%, depending on the strategy HISTORICAL S&P 500 RETURNS S&P 500 Returns Average Source: Standard & Poor’s LCD Private equity fund structure. PRIVATE EQUITY FIRM LIMITED PARTNERS (Investors) (Public pension funds, corporate pension funds, insurance companies, high net worth individuals, family offices, endowments, banks, foundations, funds-of-funds, etc.) Management Company General Partner Fund Ownership Fund Investment Management PRIVATE EQUITY FUND (Limited Partnership) Fund’s Ownership of Portfolio Investments Etc. -
Investor Lunch, New York – 3 March 2006
Investor lunch, New York – 3 March 2006 1 3i team Philip Yea Simon Ball Jonathan Russell Michael Queen Jo Taylor Chris Rowlands Group Chief Executive Group Finance Director Managing Partner Managing Partner Managing Partner Head of Group Markets Buyouts Growth Capital Venture Capital Patrick Dunne Anil Ahuja Gustav Bard Graeme Sword Guy Zarzavatdjian Group Communications Managing Director, India Managing Director, Director, Oil and Gas Managing Director, Director Nordic Region France 2 Investor lunch, New York – 3 March 2006 Contents • Introduction to 3i • The private equity market • Interim results to 30 September 2005 • Investor relations • Closing remarks 3 Investor lunch, New York – 3 March 2006 Introduction to 3i 3i at a glance • A world leader in private equity and venture capital • Established 1945; IPO on London Stock Exchange 1994 (IPO at 272p) • Market capitalisation £5.0bn (as at 31 January 2006) • 3i has invested over £15bn in over 14,000 businesses • Portfolio value £4.4bn, in 1,285 businesses (as at 30 September 2005) • Network of teams located in 14 countries in Europe, Asia and the US • 3i also manages and advises third party funds totalling £1.8bn (as at 30 September 2005) • Member of the MSCI Europe, FTSE100, Eurotop 300 and DJ Stoxx indices 4 Investor lunch, New York – 3 March 2006 Introduction to 3i Our Board • Chairman Baroness Hogg • Six independent non-executive directors − Oliver Stocken (Deputy Chairman; Senior Independent Director) − Dr Peter Mihatsch − Christine Morin-Postel − Danny Rosenkranz − Sir Robert Smith -
Corporate Venturing Report 2019
Corporate Venturing 2019 Report SUMMIT@RSM All Rights Reserved. Copyright © 2019. Created by Joshua Eckblad, Academic Researcher at TiSEM in The Netherlands. 2 TABLE OF CONTENTS LEAD AUTHORS 03 Forewords Joshua G. Eckblad 06 All Investors In External Startups [email protected] 21 Corporate VC Investors https://www.corporateventuringresearch.org/ 38 Accelerator Investors CentER PhD Candidate, Department of Management 43 2018 Global Startup Fundraising Survey (Our Results) Tilburg School of Economics and Management (TiSEM) Tilburg University, The Netherlands 56 2019 Global Startup Fundraising Survey (Please Distribute) Dr. Tobias Gutmann [email protected] https://www.corporateventuringresearch.org/ LEGAL DISCLAIMER Post-Doctoral Researcher Dr. Ing. h.c. F. Porsche AG Chair of Strategic Management and Digital Entrepreneurship The information contained herein is for the prospects of specific companies. While HHL Leipzig Graduate School of Management, Germany general guidance on matters of interest, and every attempt has been made to ensure that intended for the personal use of the reader the information contained in this report has only. The analyses and conclusions are been obtained and arranged with due care, Christian Lindener based on publicly available information, Wayra is not responsible for any Pitchbook, CBInsights and information inaccuracies, errors or omissions contained [email protected] provided in the course of recent surveys in or relating to, this information. No Managing Director with a sample of startups and corporate information herein may be replicated Wayra Germany firms. without prior consent by Wayra. Wayra Germany GmbH (“Wayra”) accepts no Wayra Germany GmbH liability for any actions taken as response Kaufingerstraße 15 hereto. -
Partners Group Private Equity
SECURITIES AND EXCHANGE COMMISSION FORM NPORT-P Filing Date: 2020-08-26 | Period of Report: 2020-06-30 SEC Accession No. 0001752724-20-174334 (HTML Version on secdatabase.com) FILER Partners Group Private Equity (Master Fund), LLC Mailing Address Business Address 1114 AVENUE OF THE 1114 AVENUE OF THE CIK:1447247| IRS No.: 800270189 | State of Incorp.:DE | Fiscal Year End: 0331 AMERICAS AMERICAS Type: NPORT-P | Act: 40 | File No.: 811-22241 | Film No.: 201137479 37TH FLOOR 37TH FLOOR NEW YORK NY 10036 NEW YORK NY 10036 212-908-2600 Copyright © 2020 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document ITEM 1. SCHEDULE OF INVESTMENTS. The Schedule(s) of Investments is attached herewith. Partners Group Private Equity (Master Fund), LLC (a Delaware Limited Liability Company) Consolidated Schedule of Investments — June 30, 2020 (Unaudited) The unaudited consolidated schedule of investments of Partners Group Private Equity (Master Fund), LLC (the “Fund”), a Delaware limited liability company that is registered under the Investment Company Act of 1940, as amended (the “Investment Company Act”), as a non-diversified, closed-end management investment company, as of June 30, 2020 is set forth below: INVESTMENT PORTFOLIO AS A PERCENTAGE OF TOTAL NET ASSETS Copyright © 2020 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document Partners Group Private Equity (Master Fund), LLC (a Delaware Limited Liability Company) Consolidated Schedule of Investments — June 30, 2020 (Unaudited) Acquisition Fair Industry Shares Date Value Common Stocks (2.38%) Asia - Pacific (0.06%) Alibaba Group Holding Ltd. Technology 06/19/20 4,439 $ 957,581 APA Group Utilities 02/11/16 360,819 2,765,432 Total Asia - Pacific (0.06%) 3,723,013 North America (1.09%) American Tower Corp. -
EMEA Private Equity Market Snapshot
• EMEA Emerging Markets Flourish Despite Brexit Jitters EMEA Private Equity • Specialist Mid-Market GPs Face Stiff Competition Market Snapshot • EMEA Consumer Products Losing Ground to US Targets • UK Large Caps, UK Mid-Caps: Spot Any Difference? October 2016 │ Issue 11 1 EMEA Private Equity Market Snapshot Editor’s Note Welcome to the eleventh issue of the EMEA Private Equity Market Snapshot, a quarterly publication focusing on the private equity [PE] market in Europe, the Middle East & Africa [EMEA] from S&P Global Market Intelligence. This issue leads with a review of the third quarter of 2016, noting the attractiveness of EMEA-based targets continu es to weaken in the eyes of foreign private equity buyers, with the UK faring the worst, while the Emerging Markets bucked this trend. We also take a look at the Brexit effect on the slowdown of activity of EMEA GPs and venture capital firms. We visit the UK Mid-Markets where unpredictability is the order of the day: subdued global investment while UK-based GPs remain optimistic, being left behind by its European neighbours and being the victim of intrusion from outsiders. The Consumer Products sector – the long-term darling of the private equity industry is going through a tumultuous time in EMEA as well as losing ground to the US. Is this sector in danger of losing its appeal? Our final piece looks at the UK Billion Dollar Funds and finds it short of investments and not investors and touches upon the private equity industry moving away from financial engineering towards value creation strategies which require longer holding periods. -
Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand Its Precision Medicine Platform
FOR IMMEDIATE RELEASE Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform Accelerates Caris’ rapid growth as the market leader reshaping precision oncology through basic science research and the application of artificial intelligence to one of the largest clinico-genomic databases Capital raise represents one of the largest private financings in precision medicine supported by a diverse, high-quality syndicate of leading investors IRVING, Texas, May 11, 2021 – Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine, announced an $830 million growth equity round at a post-money valuation of $7.83 billion. With this investment, Caris has raised approximately $1.3 billion in external financing since 2018. This financing represents one of the largest capital raises in precision medicine and includes a diverse syndicate of leading investors. The round was led by Sixth Street, a leading global investment firm making its third investment in Caris since 2018. Funds and accounts advised by T. Rowe Price Associates, Inc., Silver Lake, Fidelity Management & Research Company LLC, and Coatue were significant participants in the round. Additional investors included Columbia Threadneedle Investments, Canada Pension Plan Investment Board, Millennium Management, Neuberger Berman Funds, Highland Capital Management, Rock Springs Capital, OrbiMed, ClearBridge Investments, Tudor Investment Corporation, Eaton Vance Equity (Morgan Stanley), Pura Vida Investments and First Light Asset Management. All existing investors from the 2020 financing participated in this deal along with a number of new investors. The Caris Molecular Intelligence approach allows oncologists to assess all 22,000 genes in both DNA and RNA, utilizing whole exome sequencing, whole transcriptome sequencing, protein analysis, and proprietary AI models and signatures. -
Eurazeo Confirms Its Excellent Growth
EURAZEO CONFIRMS ITS EXCELLENT GROWTH MOMENTUM IN THE FIRST QUARTER OF 2021: AUM +21% OVER 12 MONTHS AND REVENUES +20% EXCLUDING TRAVEL AND LEISURE Paris, May 20, 2021 Asset management momentum strengthens at end-March • Assets Under Management (AUM): €22.7bn, +21% over LTM, of which +27% for third party • Third-party fundraising: €785m at end-March and c.€1,200m YTD, versus €283m in Q1 2020 • Management fees: €59m, of which +13% for limited partners (+4% overall1 given balance sheet divestments) • The Group expects further growth in fundraising in 2021 thanks to the strong market attractiveness of its current funds, particularly for small-mid buyout, growth and private debt funds Strong growth in portfolio performance • Portfolio economic revenue2 up +20% in Q1 2021 year-on-year (+15% compared to Q1 2019), excluding the Travel & Leisure segment • 61% increase in revenues of Growth portfolio companies (non-consolidated) • Early recovery prospects in Travel & Leisure (10% of NAV) Sustained investment activity • €1.1bn invested (€0.5bn in Q1 2020), with business flows in buoyant sectors notably tech (Questel, PPRO, Message Bird), consumer tech (UPD, Aroma-Zone) and financial services (Groupe Premium) • A high level of asset divestments expected in 2021-2022, as announced Balance sheet remains robust • NAV per share of €85.5 (not revalued quarterly) • Net cash and cash equivalents of €255m at end-March – confirmed RCF of €1.5bn • Dry powder of €3.7bn Virginie Morgon, Chairwoman of the Executive Board, stated: “This first quarter of 2021 reflects Eurazeo's growth momentum in all aspects of its business. The growth in our fundraising and assets under management, but also the strong rebound in our portfolio activity, the sustained pace of our investments in growth sectors, value-creating exits and our ability to support the major shifts towards a more sustainable economy perfectly illustrate our "Power Better Growth" positioning and its attractiveness.